Cite

HARVARD Citation

    Yang, T. et al. (2021). Adverse Cerebral Cardiovascular Events Associated With Checkpoint Kinase 1 Inhibitors. Journal of cardiovascular pharmacology. 77 (5), p. . [Online]. 
  
Back to record